Interleukin Genetics, Inc

(AMEX:ILI)

0.35

-0.04 (-10.26%)

Dec 04 - Close

Open
0.38
High
0.38
Low
0.35
Vol.
9.60K
Mkt Cap
12.40M
52Wk High
1.75
52Wk Low
0.21
Avg. Vol.
81.50K
P/E (Trailing)
-1.74
Beta
0.44
Short %
0.20%
Div. Yield
—

After-Hours 0.38 +0.03 (8.57%) Thu, 4 Dec 2008 7:40 PM

Company Profile

Interleukin Genetics, Inc

135 Beaver Street

Waltham, MA 02452

United States - Map

Phone: (781) 398-0700

Fax: (781) 398-0720

Website: www.ilgenetics.com

State of incorporation: Delaware

CEO: Lewis H. Bender

Employees: 27

Sector: Healthcare

Industry Group: Drugs

Industry: Diagnostic Substances

Develops genetic diagnostic test

The Company and its subsidiaries is engaged in developing, acquiring, and commercializing personalized health products that could help individuals improve and maintain their health through preventive measures.

Recent news for ILI

Recent opinions on ILI

No recent Opinions for ILI

No members own ILI

Member sentiment: Neutral